Elicio Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Elicio Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Elicio Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Elicio Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $77k | 7.0k | 10.94 |
| 2025-06-30 | $47k | 6.0k | 7.72 |
| 2025-03-31 | $131k | 21k | 6.16 |
| 2024-12-31 | $86 | 17 | 5.12 |
| 2024-09-30 | $4.3k | 848 | 5.06 |
| 2024-06-30 | $69 | 17 | 4.12 |
| 2024-03-31 | $122 | 16 | 7.63 |
| 2023-12-31 | $133 | 16 | 8.31 |
| 2023-09-30 | $135 | 16 | 8.44 |
| 2023-06-30 | $6.1k | 645 | 9.50 |